These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 20408439

  • 21. Recognition of HLA class I-restricted beta-cell epitopes in type 1 diabetes.
    Ouyang Q, Standifer NE, Qin H, Gottlieb P, Verchere CB, Nepom GT, Tan R, Panagiotopoulos C.
    Diabetes; 2006 Nov; 55(11):3068-74. PubMed ID: 17065344
    [Abstract] [Full Text] [Related]

  • 22. Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes.
    Antonelli A, Tuomi T, Nannipieri M, Fallahi P, Nesti C, Okamoto H, Groop L, Ferrannini E.
    Diabetologia; 2002 Sep; 45(9):1298-306. PubMed ID: 12242463
    [Abstract] [Full Text] [Related]

  • 23. Differential expression and regulation of MHC products in the endocrine and exocrine cells of the human pancreas.
    Pujol-Borrell R, Todd I, Doshi M, Gray D, Feldmann M, Bottazzo GF.
    Clin Exp Immunol; 1986 Jul; 65(1):128-39. PubMed ID: 3098471
    [Abstract] [Full Text] [Related]

  • 24. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
    Ishii M, Hasegawa G, Fukui M, Obayashi H, Ohta M, Ogata M, Yoshioka K, Kitagawa Y, Nakano K, Yoshikawa T, Nakamura N.
    Immunol Lett; 2005 Jul 15; 99(2):180-5. PubMed ID: 16009268
    [Abstract] [Full Text] [Related]

  • 25. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
    Jaeger C, Allendörfer J, Hatziagelaki E, Dyrberg T, Bergis KH, Federlin K, Bretzel RG.
    Horm Metab Res; 1997 Oct 15; 29(10):510-5. PubMed ID: 9405979
    [Abstract] [Full Text] [Related]

  • 26. Fulminant type 1 diabetes mellitus-like presentation in a Hispanic woman in the United States.
    McCauley RA, Wang X.
    Diabetes Metab; 2011 Sep 15; 37(4):356-8. PubMed ID: 21684789
    [Abstract] [Full Text] [Related]

  • 27. [Prevalence of type 1 diabetes-specific autoantibodies and of certain HLA patterns in celiac disease].
    Schilling I, Conrad K, Füssel M, Henker J.
    Dtsch Med Wochenschr; 2003 Jan 31; 128(5):185-9. PubMed ID: 12557109
    [Abstract] [Full Text] [Related]

  • 28. Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies.
    Mallone R, Ortolan E, Pinach S, Volante M, Zanone MM, Bruno G, Baj G, Lohmann T, Cavallo-Perin P, Malavasi F.
    Diabetologia; 2002 Dec 31; 45(12):1667-77. PubMed ID: 12488956
    [Abstract] [Full Text] [Related]

  • 29. Etiology and pathogenesis of type 1 diabetes.
    Scherbaum WA.
    Horm Metab Res Suppl; 1992 Dec 31; 26():111-6. PubMed ID: 1490674
    [Abstract] [Full Text] [Related]

  • 30. [GAD antibody in IDDM].
    Yokota I, Shima K.
    Rinsho Byori; 1998 Apr 31; 46(4):331-7. PubMed ID: 9594623
    [Abstract] [Full Text] [Related]

  • 31. [Fulminant type 1 diabetes].
    Imagawa A, Hanafusa T.
    Nihon Rinsho; 2006 Sep 28; Suppl 3():37-41. PubMed ID: 17022496
    [No Abstract] [Full Text] [Related]

  • 32. Pathophysiological mechanisms involving aggressive islet cell destruction in fulminant type 1 diabetes.
    Tanaka S, Aida K, Nishida Y, Kobayashi T.
    Endocr J; 2013 Sep 28; 60(7):837-45. PubMed ID: 23774118
    [Abstract] [Full Text] [Related]

  • 33. Development of fulminant Type 1 diabetes with thrombocytopenia after influenza vaccination: a case report.
    Yasuda H, Nagata M, Moriyama H, Kobayashi H, Akisaki T, Ueda H, Hara K, Yokono K.
    Diabet Med; 2012 Jan 28; 29(1):88-9. PubMed ID: 21781156
    [Abstract] [Full Text] [Related]

  • 34. Fulminant type 1 diabetes in China: a case report and review of the literature.
    Feng YF, Yao MF, Li Q, Sun Y, Li CJ, Shen JG.
    J Zhejiang Univ Sci B; 2010 Nov 28; 11(11):848-50. PubMed ID: 21043053
    [Abstract] [Full Text] [Related]

  • 35. Diagnosis of fulminant type 1 diabetes mellitus in an autopsy case with postmortem changes.
    Mizutani T, Yoshimoto T, Kaneko R, Ishii A.
    Leg Med (Tokyo); 2011 Sep 28; 13(5):250-3. PubMed ID: 21821459
    [Abstract] [Full Text] [Related]

  • 36. Fulminant type 1 diabetes--an important subtype in East Asia.
    Imagawa A, Hanafusa T.
    Diabetes Metab Res Rev; 2011 Nov 28; 27(8):959-64. PubMed ID: 22069293
    [Abstract] [Full Text] [Related]

  • 37. Pancreatic exocrine and endocrine events occur concomitantly but independently during the course of fulminant type 1 diabetes.
    Kahara T, Takamura T, Sakurai M, Misu H, Usuda R, Hayakawa T, Nishimura Y, Bando Y, Nagaoka T, Nagai Y, Kaneko S.
    Diabetes Res Clin Pract; 2006 Mar 28; 71(3):241-6. PubMed ID: 16112239
    [Abstract] [Full Text] [Related]

  • 38. Pancreatic beta and alpha cells are both decreased in patients with fulminant type 1 diabetes: a morphometrical assessment.
    Sayama K, Imagawa A, Okita K, Uno S, Moriwaki M, Kozawa J, Iwahashi H, Yamagata K, Tamura S, Matsuzawa Y, Hanafusa T, Miyagawa J, Shimomura I.
    Diabetologia; 2005 Aug 28; 48(8):1560-4. PubMed ID: 15991022
    [Abstract] [Full Text] [Related]

  • 39. A case of abrupt onset autoimmune type 1 diabetes mimicking fulminant type 1 diabetes.
    Makino S, Hamada S, Iwata M, Fujiwara M.
    Endocr J; 2009 Aug 28; 56(9):1113-7. PubMed ID: 19680007
    [Abstract] [Full Text] [Related]

  • 40. Recent findings on fulminant type 1 diabetes.
    Liu L, Zeng L, Sang D, Lu Z, Shen J.
    Diabetes Metab Res Rev; 2018 Jan 28; 34(1):. PubMed ID: 28817230
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.